Support for preferred stock proposal hits new high of 89%, special meeting scheduled for Sept. 11 Page 1

SOMERSET, NJ, August 23, 2024 (GLOBE NEWSWIRE) — CAreCloud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDO, CCLDP), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced that approximately 89% of the shares represented by proxies returned to date for the Company’s Series A Preferred Stock special meeting (“Special Meeting”) have indicated that they vote “FOR” the amendment to the Company’s Certificate of Designations, Preferences and Rights of its Series A Preferred Stock (the “Preferred Stock Proposal”). Due to the significantly narrowed gap for approval of the Preferred Stock Proposal, the Special Meeting will be reconvened on Wednesday, September 11, 2024 at 11:00 a.m. Eastern Time.

“We are very pleased with the outpouring of support for our Preferred Stock Proposal,” said Stephen Snyder, President of CareCloud. “With a favorable vote recommendation from proxy voting advisor Glass Lewis, approval from nearly 9 out of 10 responding shareholders, and receipt of 87.8% of the total 3.02 million required proxy votes, we believe we are very close to obtaining approval of the Preferred Stock Proposal.”